In December 2019, a novel coronavirus (Covid-19) associated with human to human transmission and severe human infection has been recently reported from the city of Wuhan in China Hubei Province. The first Covid-19 in Turkey comparative findings of their patients can help spread the infection, early diagnosis, treatment and control. This study in Turkey Siirt State Hospital in Covid-19 diagnosed patients and 12 healthy normal consists of 12 patients. Data from electronic medical records were taken retrospectively and patient and control group data were compared statistically. Statistically decreased lymphocyte (1.23 ± 0.66), WBC (5.00 ± 1.50), neutrophil (3.32 ± 1.77), platelets (175.08 ± 44.18) in Covid-19 patients compared to the control group and increased D-Dimer (595.08 ± 185.87), ferritin (236.31 ± 50.36), CRP (12.43 ± 4.31), lactate (1.37 ± 0.39), CK (189.50 ± 63.66) levels, other clinical findings and CT images were found to be compatible with Covid-19. This study is the first comparative study on pandemic Covid-19 in Siirt/Turkey. These prognostic parameters are important for a specific clinical diagnosis, which may contribute to reflect the evolution of CT findings and the severe course of the disease and the worst clinical picture.
___
1. Sun ML, Yang JM, Sun YP, et al. Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia. Zhonghua Jie He He Hu Xi Za Zhi, 2020;43:219-22.
2. Lippi G, Plebani M. The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge. Diagnosis. 2020;7:79-81.
3. Pang J, Wang MX, Ang IYH, et al. Potential rapid diagnostics, vaccine, and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med. 2020;9:623.
4. Jin YH, Cai L, Cheng ZS, Cheng H, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4.
5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020;395:497-506.
6. Lei J, Li J, Li X, et al. CT Imaging of the 2019 Novel Coronavirus (2019- nCoV) Pneumonia. Radiology. 2020;295:18.
7. Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. J Eur Radiol. 2020;30:3306-9.
8. Zhang X, Song W, Liu X, et al. CT image of novel coronavirus pneumonia: a case report. Jpn J Radiol. 2020;38:407-8.
9. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58:1116- 20.
10. Ran L, Chen X, Wang Y, et al. Risk Factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China. Clin Infect Dis. 2020;ciaa287.
11. Chung M, Bernheim A, Mei X, et.al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020;295:202–7.
12. Shi H, Han X, Zheng C. Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China. Radiology. 2020;295:20.
13. Song F, Shi N, Shan F, et al. Emerging 2019 Novel Coronavirus (2019- nCoV) Pneumonia. Radiology. 2020;295:210–7.
14. Fang Y, Zhang H, Xu Y, et al. CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295:208–9.
15. Duan Y and Qin J. Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295:21.
16. Huang P, Liu T, Huang L, et al. Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion. Radiology. 2020;295:22-3.